Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open‐Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers

Documenti analoghi

• Pharmacokinetics and Bioequivalence of Fixed‐Dose Combination of Simvastatin and Ezetimibe Tablets: A Randomized, Crossover, Open‐Label Study in Healthy Volunteers
  di: Chuei Wuei Leong, et al.
  Pubblicazione: (2024)
• Pharmacokinetics and Bioequivalence of two Empagliflozin Tablet Formulations: Results From a Randomized, Open‐Label, Crossover Study in Fasting Healthy Volunteers
  di: Kar Ming Yee, et al.
  Pubblicazione: (2025)
• Bioequivalence and Pharmacokinetic Evaluation of Regorafenib Tablets in Healthy Chinese Volunteers
  di: Zhaoyu Wang, et al.
  Pubblicazione: (2024)
• Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers
  di: Pan Luo, et al.
  Pubblicazione: (2026)
• Bioequivalence and Pharmacokinetic Evaluation of Gliclazide Modified‐Release Tablets in Healthy Chinese Volunteers
  di: Kejia Fu, et al.
  Pubblicazione: (2026)